View the Latest Edition of BioNetwork Here

BioNetwork West 2016 (past event)

October 05 - 07, 2016

1.888.482.6012

Innovative Dealmaking

Pre-Event Networking Activity The Latest Trends in Biopharma Partnering Innovative Dealmaking Day Three: Connecting Dealmakers

+ Show All Session Details

06:30 - 07:45 Sunrise Jog

07:45 - 08:45 Registration And Networking Breakfast

08:45 - 08:50 Welcoming Remarks

08:50 - 09:00 Chairperson’s Opening Address

Speaker:
Andrew Mitchell Director, Product Strategy and Marketing, Life Sciences Intralinks

Andrew Mitchell

Director, Product Strategy and Marketing, Life Sciences
Intralinks

See Bio

09:00 - 09:15 Biotech Spotlight | Resverlogix Corp.

Speaker:
Kenneth Lebioda Senior Vice President, Business and Corporate Development Resverlogix Corp.

Kenneth Lebioda

Senior Vice President, Business and Corporate Development
Resverlogix Corp.

See Bio

09:15 - 09:30 Biotech Spotlight | Redhill Biopharm LTD.

Speaker:
Adi Frish Senior Vice President, Business Development and Licensing Redhill Biopharm LTD

Adi Frish

Senior Vice President, Business Development and Licensing
Redhill Biopharm LTD

See Bio

General Session

09:30 - 10:10 Panel Discussion | The Evolution of Risk Sharing Models in Today’s Market

Moderator:
Scott E. Goedeke President Viscadia
Speakers:
Stuart Mackey Global Head of Business Development Daiichi Sankyo
Christoph Pittius Vice President, Head of Transactions AstraZeneca
Peter Ginsberg AVP, Business Development United Therapeutics Corporation
Patrick Johnson Vice President of Business Development Allergan, Inc.
Rachna Khosla Executive Director, Business Development Amgen

• Overview of the latest variations on risk sharing
• How are up front payments being minimized?
• What are the different investment vehicles being used?

Scott E. Goedeke

President
Viscadia

See Bio

Stuart Mackey

Global Head of Business Development
Daiichi Sankyo

See Bio

Christoph Pittius

Vice President, Head of Transactions
AstraZeneca

See Bio

Peter Ginsberg

AVP, Business Development
United Therapeutics Corporation

See Bio

Patrick Johnson

Vice President of Business Development
Allergan, Inc.

See Bio

Rachna Khosla

Executive Director, Business Development
Amgen

See Bio

1:1 Partnering Meetings

09:30 - 10:10 Opening Of 1:1 Partnering Meetings

General Session

10:10 - 10:50 Networking And Refreshment Break

1:1 Partnering Meetings

10:10 - 10:50 Opening Of 1:1 Partnering Meetings

General Session

10:50 - 11:30 Panel Discussion | From Sourcing to Alliance Management, The Ins and Outs of Hybrid Deals

Speakers:
Eric Risser Senior Vice President, Business Development MacroGenics, Inc.
Nassim Usman Chief Executive Officer Catalyst Biosciences
Moderator:
Stephen Thau Partner Morrison & Foerster

The industry continues to evolve toward evermore complex transactions for the development and commercialization of products. With the increasing complexity of deal structure and collaboration objectives, effective alliance management requires new tools and approaches.
• Overview of emerging practices for deals that rely heavily on partnerships
• Establishing governance and strategies to optimize the prospects for success
• Working toward alignment internally and externally on global deals

Eric Risser

Senior Vice President, Business Development
MacroGenics, Inc.

See Bio

Stephen Thau

Partner
Morrison & Foerster

See Bio

Nassim Usman

Chief Executive Officer
Catalyst Biosciences

See Bio

1:1 Partnering Meetings

10:50 - 11:30 Opening Of 1:1 Partnering Meetings

General Session

11:30 - 11:45 Biotech Spotlight | NeOnc Technologies

Speaker:
Thomas Chen Chief Executive Officer NeOnc Technologies

Thomas Chen

Chief Executive Officer
NeOnc Technologies

See Bio

1:1 Partnering Meetings

11:30 - 11:45 Opening Of 1:1 Partnering Meetings

General Session

11:45 - 12:00 Biotech Spotlight | Amunix

Speaker:
Volker Schellenberger President & CEO Amunix

Volker Schellenberger

President & CEO
Amunix

See Bio

1:1 Partnering Meetings

11:45 - 12:00 Opening Of 1:1 Partnering Meetings

General Session

12:00 - 12:15 Biotech Spotlight | Oncoceutics

Speaker:
Lee Schalop Chief Business Officer Oncoceutics, Inc.

Lee Schalop

Chief Business Officer
Oncoceutics, Inc.

See Bio

1:1 Partnering Meetings

12:00 - 12:15 Opening Of 1:1 Partnering Meetings

General Session

12:15 - 12:30 Biotech Spotlight | Immunomic Therapeutics, Inc.

Speaker:
Sia Anagnostou Senior Director, Corporate Development Immunomic Therapeutics, Inc.

Sia Anagnostou

Senior Director, Corporate Development
Immunomic Therapeutics, Inc.

See Bio

1:1 Partnering Meetings

12:15 - 12:30 Opening Of 1:1 Partnering Meetings

General Session

12:30 - 13:40 Networking Luncheon

1:1 Partnering Meetings

12:30 - 13:40 Opening Of 1:1 Partnering Meetings

13:40 - 14:20 Panel Discussion | A Thorough and Swift Approach to Due Diligence

Speakers:
Robert Bagdorf Vice President of Worldwide Business Development Pfizer Inc.
Patrick Gallagher Vice President of Business Development Noven Pharmaceuticals, Inc.
Kathryn Gregory Executive Director, Business Development Purdue Pharma
Adam Marcus Principal DRI Capital
Younes Bekkali Director, BD&L, Strategic Transactions Boehringer Ingelheim Pharmaceuticals, Inc.
Moderator:
Ashlee Dunston Director of Healthcare Research Guidepoint

• What are the key challenges in conducting diligence?
• What do you perceive to be the key challenges?
• What approaches are most effective in getting validated insights faster?

Robert Bagdorf

Vice President of Worldwide Business Development
Pfizer Inc.

See Bio

Patrick Gallagher

Vice President of Business Development
Noven Pharmaceuticals, Inc.

See Bio

Kathryn Gregory

Executive Director, Business Development
Purdue Pharma

See Bio

Ashlee Dunston

Director of Healthcare Research
Guidepoint

See Bio

Adam Marcus

Principal
DRI Capital

See Bio

Younes Bekkali

Director, BD&L, Strategic Transactions
Boehringer Ingelheim Pharmaceuticals, Inc.

See Bio

General Session

14:20 - 15:00 Panel Discussion | From Disruptive to Traditional, The Latest Trends in VC Funding

Speakers:
Asish Xavier Vice President, Venture Investments Johnson & Johnson
Elaine Jones Executive Director, Venture Capital Pfizer Inc.
Leon Chen Venture Partner OrbiMed Advisors
Jeremy Bender Chief Operating Officer Tizona
Rajeev Dadoo Partner SR One
Moderator:
Anshul Thakral Senior Vice President PPD Biotech

• What are the latest developments in the emerging model of companies started by VCs?
• What is the current appetite for risk across the biopharma venture community?
• How do strategies differ from large VC to new venture funds?

Asish Xavier

Vice President, Venture Investments
Johnson & Johnson

See Bio

Elaine Jones

Executive Director, Venture Capital
Pfizer Inc.

See Bio

Leon Chen

Venture Partner
OrbiMed Advisors

See Bio

Anshul Thakral

Senior Vice President
PPD Biotech

See Bio

Jeremy Bender

Chief Operating Officer
Tizona

See Bio

Rajeev Dadoo

Partner
SR One

See Bio

1:1 Partnering Meetings

14:20 - 15:00 1:1 Partnering Meetings

General Session

15:00 - 15:40 Networking And Refreshment Break

1:1 Partnering Meetings

15:00 - 15:40 1:1 Partnering Meetings

General Session

15:40 - 15:55 Biotech Spotlight | KLOX Technologies

Speaker:
Alex Chang Head, Business Development and Alliance Management KLOX Technologies

Alex Chang

Head, Business Development and Alliance Management
KLOX Technologies

See Bio

1:1 Partnering Meetings

15:40 - 15:55 1:1 Partnering Meetings

General Session

15:55 - 16:10 Biotech Spotlight | Sequence Bio

Speaker:
Tyler Wish Chief Executive Officer Sequence Bio

Tyler Wish

Chief Executive Officer
Sequence Bio

See Bio

1:1 Partnering Meetings

15:55 - 16:10 1:1 Partnering Meetings

General Session

16:10 - 16:25 Biotech Spotlight | Enable Injections

Speaker:
Jeannie Joughin Vice President, Corporate Development Enable Injections

Jeannie Joughin

Vice President, Corporate Development
Enable Injections

See Bio

1:1 Partnering Meetings

16:10 - 16:25 1:1 Partnering Meetings

General Session

16:25 - 17:05 Panel Discussion | Key Strategies for Success in Early Stage Partnering

Moderator:
Scott Shaunessy CEO ideaPoint
Speakers:
Steven Bartz Director, Worldwide Licensing Merck
Michael Bayewitch Director, S&E, Biologics Teva Pharmaceuticals USA
Lisa Beck Head of Transactions, Global Business Development Alexion Pharmaceuticals, Inc
Dr. Gary VanSavage Senior Director, Transactions, Janssen Business Development Johnson & Johnson
Sylvaine Cases Senior Director, External Innovation Sanofi

• What data are buyers looking for?
• How can you best differentiate your product in a crowded space?
• With pharma and VCs taking a greater interest in early stage opportunities, what can biotech and academic institutions do to be most competitive?